Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Control Release ; 370: 811-820, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38754632

RESUMO

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and life-threatening lung disease for which treatment options are limited. Glycyrrhetinic acid (GA) is a triterpenoid with multiple biological effects, such as anti-inflammatory and anti-fibrotic properties. Herein, inhalable milk-derived extracellular vesicles (mEVs) encapsulating GA (mEVs@GA) were screened and evaluated for IPF treatment. The results indicated that the loading efficiency of GA in mEVs@GA was 8.65%. Therapeutic effects of inhalable mEVs@GA were investigated in vitro and in vivo. The mEVs@GA demonstrated superior anti-inflammatory effects on LPS-stimulated MHS cells. Furthermore, repeated noninvasive inhalation delivery of mEVs@GA in bleomycin-induced IPF mice could decrease the levels of transforming growth factors ß1 (TGF-ß1), Smad3 and inflammatory cytokines IL-6, IL-1ß and TNF-α. The mEVs@GA effectively diminished the development of fibrosis and improved pulmonary function in the IPF mice model at a quarter of the dose compared with the pirfenidone oral administration group. Additionally, compared to pirfenidone-loaded mEVs, mEVs@GA demonstrated superior efficacy at the same drug concentration in the pharmacodynamic study. Overall, inhaled mEVs@GA have the potential to serve as an effective therapeutic option in the treatment of IPF.


Assuntos
Citocinas , Vesículas Extracelulares , Ácido Glicirretínico , Fibrose Pulmonar Idiopática , Camundongos Endogâmicos C57BL , Leite , Animais , Ácido Glicirretínico/administração & dosagem , Fibrose Pulmonar Idiopática/tratamento farmacológico , Fibrose Pulmonar Idiopática/induzido quimicamente , Administração por Inalação , Leite/química , Citocinas/metabolismo , Anti-Inflamatórios/administração & dosagem , Anti-Inflamatórios/uso terapêutico , Bleomicina/administração & dosagem , Masculino , Pulmão/metabolismo , Pulmão/efeitos dos fármacos , Camundongos , Humanos , Linhagem Celular , Portadores de Fármacos/química , Portadores de Fármacos/administração & dosagem , Proteína Smad3/metabolismo
2.
AAPS PharmSciTech ; 25(5): 117, 2024 May 28.
Artigo em Inglês | MEDLINE | ID: mdl-38806874

RESUMO

Eugenol (Eug) holds potential as a treatment for bacterial rhinosinusitis by nasal powder drug delivery. To stabilization and solidification of volatile Eug, herein, nasal inhalable γ-cyclodextrin metal-organic framework (γ-CD-MOF) was investigated as a carrier by gas-solid adsorption method. The results showed that the particle size of Eug loaded by γ-CD-MOF (Eug@γ-CD-MOF) distributed in the range of 10-150 µm well. In comparison to γ-CD and ß-CD-MOF, γ-CD-MOF has higher thermal stability to Eug. And the intermolecular interactions between Eug and the carriers were verified by characterizations and molecular docking. Based on the bionic human nasal cavity model, Eug@γ-CD-MOF had a high deposition distribution (90.07 ± 1.58%). Compared with free Eug, the retention time Eug@γ-CD-MOF in the nasal cavity was prolonged from 5 min to 60 min. In addition, the cell viability showed that Eug@γ-CD-MOF (Eug content range 3.125-200 µg/mL) was non-cytotoxic. And the encapsulation of γ-CD-MOF could not reduce the bacteriostatic effect of Eug. Therefore, the biocompatible γ-CD-MOF could be a potential and valuable carrier for nasal drug delivery to realize solidification and nasal therapeutic effects of volatile oils.


Assuntos
Administração Intranasal , Portadores de Fármacos , Sistemas de Liberação de Medicamentos , Eugenol , Estruturas Metalorgânicas , Pós , Estruturas Metalorgânicas/química , Pós/química , Humanos , Eugenol/química , Eugenol/administração & dosagem , Eugenol/farmacologia , Administração Intranasal/métodos , Sistemas de Liberação de Medicamentos/métodos , Portadores de Fármacos/química , Tamanho da Partícula , Sobrevivência Celular/efeitos dos fármacos , Simulação de Acoplamento Molecular/métodos , gama-Ciclodextrinas/química , Estabilidade de Medicamentos , Antibacterianos/administração & dosagem , Antibacterianos/química , Antibacterianos/farmacologia , Ciclodextrinas/química , Cavidade Nasal/metabolismo
3.
J Pharm Biomed Anal ; 245: 116153, 2024 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-38636194

RESUMO

Extracellular vesicles (EVs) are nano-sized lipid-membrane vesicles involved in intercellular communication and reflecting the physiological and pathological processes of their parental cells. Rapid isolation of EVs with low cost is an essential precondition for downstream function exploration and clinical applications. In this work, we designed a novel EVs isolation device based on the boronated organic framework (BOF) coated recyclable microfluidic chip (named EVs-BD) to separate EVs from cell culture media. Using a reactive oxygen species responsive phenylboronic ester compound, the highly porous BOF with a pore size in the range of 10-300 nm was prepared by crosslinking γ-cyclodextrin metal-organic frameworks. A mussel-inspired polydopamine (PDA)/polyethyleneimine (PEI) coating was employed to pattern BOF on the PDMS substrate of microfluidic channels. The EVs-BD was demonstrated to offer distinct advantages over the traditional ultracentrifugation method, such as operation simplicity and safety, reduced time and expense, and low expertize requirements. All things considered, a novel approach of EV acquisition has been successfully developed, which can be customized easily to meet the requirements of various EV-relevant research.


Assuntos
Vesículas Extracelulares , Indóis , Estruturas Metalorgânicas , Polietilenoimina , Polímeros , Vesículas Extracelulares/química , Estruturas Metalorgânicas/química , Polímeros/química , Indóis/química , Polietilenoimina/química , Humanos , Técnicas Analíticas Microfluídicas/métodos , Técnicas Analíticas Microfluídicas/instrumentação , Dispositivos Lab-On-A-Chip , Espécies Reativas de Oxigênio/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...